45 days to first decision for reviewed manuscripts only
45 days to first decision for all manuscripts
128 days from submission to acceptance
27 days from acceptance to publication
23 Altmetric mentions
Dipeptidyl peptidase 4 inhibitor linagliptin can decrease the dosage of erythropoiesis-stimulating agents in patients on hemodialysis
Dipeptidyl peptidase 4 (DPP4) inhibitors are very useful for the treatment of type 2 diabetes, especially to patients undergoing hemodialysis (HD). The main action of DPP4 inhibitors is to increase the concent...
Citation: Renal Replacement Therapy 2016 2:44